Related Experiment Videos
[Cryobiology and pathologic lesions induced by freezing-thawing processes in prostatic tissue. Second part]
Angel Escudero Barrilero1, Fernando Arias Fúnez, Rafael Rodríguez Patrón Rodríguez
1Servicio de Urología, Servicio de Anatomía Patológica, Hospital Ramón y Cajal, Madrid, España.
Archivos Espanoles De Urologia
|February 18, 2005
Summary
Cryosurgery uses controlled freezing to destroy cancer cells, showing promise for prostate and kidney adenocarcinomas. This minimally invasive procedure offers a low-risk alternative for high-risk patients.
Area of Science:
- Oncology
- Surgical Technology
- Cell Biology
Context:
- Cryosurgery, a controlled freezing technique, is an emerging treatment for various cancers.
- It has demonstrated long-term efficacy in treating prostate adenocarcinoma.
- Research is exploring its potential as an alternative to partial nephrectomy for small renal adenocarcinomas.
Purpose:
- To elucidate the cellular mechanisms of cryosurgery-induced cell death.
- To analyze the pathological findings following cryosurgery.
- To evaluate the safety and feasibility of cryosurgery, particularly in high-risk patients.
Summary:
- Controlled freezing induces cell death through necrosis and apoptosis via extracellular/intracellular ice formation, dehydration, and hyperosmotic stress.
- Vascular damage, thrombus formation, and post-thaw inflammation contribute to tissue destruction.
- Pathological findings include necrosis, fibrosis, vascular changes, and metaplasia, with residual cancer in less affected areas.
Impact:
- Cryosurgery offers a minimally invasive option with scarce morbimortality, avoiding ICU admission, blood transfusions, and major cardiovascular events.
- The procedure is feasible for high-surgical-risk patients and has no age limitations.
- Its potential to replace partial nephrectomy for small renal tumors warrants further investigation.